• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Neil Minkoff, MD, Explains the Impact Formulary Has on Employer and Consumer Choice in the Health Insurance Exchanges

Article

Neil Minkoff, MD, CEO, FountainHead HealthCare, discusses the impact that formulary has on both employer and consumer choice in the health insurance exchanges.

Neil Minkoff, MD, CEO, FountainHead HealthCare, discusses the impact that formulary has on both employer and consumer choice in the health insurance exchanges. He says that the industry has reached a point where an estimated 75% to 80% of prescription drug volume is generic. However, there’s less scrutiny of pharmacy benefits in general, as that scrutiny has moved to biotech and specialty.

“The employer and the plan are in a position of needing to offer the appropriate drug to the appropriate patient because it’s become the standard of care, but not being so generous in a benefit that they suffer from adverse selection… and that’s the tight rope that both employers and plans are trying to deal with right now,” he says.

Related Videos
Andrew Kuykendall, MD, Moffitt Cancer Center
David J. Maron, MD, FASPC, Stanford University School of Medicine
Karen Vo talks about antibullying campaigns and pediatric patients with derm conditions
Hira Ghani, DO, discusses underdiagnosed skin conditions in children
Rebecca Chacko, MD.
Dr María Díez Campelo
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.